-
Study aim
-
We measure pain reduction after unilateral knee arthroplasty after adding lidocaine to morphine in a patient controlled analgesia pump.
-
Design
-
Clinical trial with a control group, with parallel groups, three blinded, randomized, phase 2-3 on 58 patients.
-
Settings and conduct
-
This study was conducted in Aria and Farabi hospitals in Mashhad. A pain pump was placed for the patients for post-operative analgesia. The pain level of the surgical site was compared with the Visual Analogue Scale method at specific time intervals. In this study, drugs were used with the same packaging and blinding was done for patients, project personnel and researchers.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients with American Society of Anesthesiologists (ASA) class 1 and 2 between 45 and 75 years old, with a Body Mass Index(BMI) in the range of 20-25 should undergo spinal anesthesia for the surgery؛ Exclusion criteria: Patients with a history of epilepsy, known kidney disease, heart block, or drug addiction, Patients with a medical history that indicates hypersensitivity to lidocaine and opioids, Patients with coagulation disorders, Patients with skin infection at the injection site, a history Moderate to severe nausea and vomiting in the past 24 hours
-
Intervention groups
-
Group A: The content of the patient controlled analgesia pump attached to the patient included 20 mg of morphine, 8 mg of Ondansetron ampoule (4 cc), 1g of Apotel (6.7 cc) and the rest of normal saline to reach a total volume of 100 cc
Group B: The content of the patient controlled analgesia pump includes 10 mg of morphine, 50 cc of lidocaine 2%, 8 mg of ampoule of Ondansetron (4 cc), 1g of Apotel (6.7 cc) and the rest of normal saline to a total volume of 100 cc.
-
Main outcome variables
-
Postoperative pain; mean arterial pressure; heart rate; nausea and vomiting; systolic pressure; diastolic pressure